CRANBURY, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (Amex: PTN) will announce its second quarter, fiscal year 2008 financial results for the period ended December 31, 2007 on February 11, 2008 before the open of the U.S. financial markets.
The Company will also conduct a teleconference and live audio webcast
hosted by Palatin's executive management team on February 11, 2008 at which
they will discuss the results of operations in greater detail and provide
an update on corporate developments.
Schedule for the Financial Results Press Release, Conference Call and Webcast
-- Q2-Fiscal Year 2008 Financial Results 2/11/2008 at 7:30 a.m. ET
-- Q2-Fiscal Year 2008 Conference 2/11/2008 at 11:00 a.m. ET
Call - Live
Domestic Dial-In Number 1-888-686-9699
International Dial-In Number 1-913-312-6699
-- Q2-Fiscal Year 2008 Conference 2/11-2/18/2008
Call - Replay
Domestic Dial-In Number 1-888-203-1112
International Dial-In Number 1-719-457-0820
Replay Passcode: 6144795
-- Webcast Live and Replay Access http://www.palatin.com
The webcast and replay can be accessed by logging on to the "Investor
Center-Webcasts" section of Palatin's website at http://www.palatin.com.
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.
|SOURCE Palatin Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved